Lingjiao Zhang

4.0k total citations · 1 hit paper
58 papers, 2.9k citations indexed

About

Lingjiao Zhang is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Lingjiao Zhang has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Neurology. Recurrent topics in Lingjiao Zhang's work include Vascular Malformations Diagnosis and Treatment (9 papers), RNA Interference and Gene Delivery (8 papers) and Intracerebral and Subarachnoid Hemorrhage Research (8 papers). Lingjiao Zhang is often cited by papers focused on Vascular Malformations Diagnosis and Treatment (9 papers), RNA Interference and Gene Delivery (8 papers) and Intracerebral and Subarachnoid Hemorrhage Research (8 papers). Lingjiao Zhang collaborates with scholars based in United States, China and United Kingdom. Lingjiao Zhang's co-authors include Maciej S. Lesniak, Yu Han, Atique U. Ahmed, Derek A. Wainwright, Alex L. Tobias, Mahua Dey, Yu Cheng, Jian Qiao, Brenda Auffinger and Ramin A. Morshed and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Lingjiao Zhang

54 papers receiving 2.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells

2016 479 citations Alan L. Chang, Jason Miska et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lingjiao Zhang United States	28	835	831	782	721	509	58	2.9k
Oliver Grauer Germany	31	636 0.8×	751 0.9×	1.2k 1.5×	848 1.2×	470 0.9×	78	3.5k
Wei Shi China	24	1.1k 1.3×	814 1.0×	683 0.9×	496 0.7×	235 0.5×	90	3.0k
Steven De Vleeschouwer Belgium	32	918 1.1×	1.2k 1.5×	1.5k 1.9×	1.1k 1.5×	269 0.5×	110	3.3k
Adam M. Sonabend United States	28	750 0.9×	551 0.7×	620 0.8×	1.0k 1.4×	395 0.8×	83	2.5k
Emilio Ciusani Italy	36	2.1k 2.5×	1.0k 1.2×	610 0.8×	959 1.3×	379 0.7×	152	4.7k
Shin Jung South Korea	34	1.2k 1.4×	599 0.7×	249 0.3×	987 1.4×	295 0.6×	204	4.0k
Douglas W. Laske United States	12	764 0.9×	363 0.4×	418 0.5×	1.0k 1.4×	429 0.8×	16	2.9k
Brenda Auffinger United States	24	992 1.2×	621 0.7×	400 0.5×	698 1.0×	598 1.2×	38	2.6k
Irina V. Balyasnikova United States	36	1.9k 2.2×	1.4k 1.7×	902 1.2×	798 1.1×	915 1.8×	113	4.2k
David Croteau United States	23	397 0.5×	344 0.4×	318 0.4×	1.0k 1.4×	221 0.4×	44	2.4k

Countries citing papers authored by Lingjiao Zhang

Since Specialization

Citations

This map shows the geographic impact of Lingjiao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjiao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjiao Zhang more than expected).

Fields of papers citing papers by Lingjiao Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjiao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjiao Zhang. The network helps show where Lingjiao Zhang may publish in the future.

Co-authorship network of co-authors of Lingjiao Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjiao Zhang. A scholar is included among the top collaborators of Lingjiao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjiao Zhang. Lingjiao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Canonica, Giorgio Walter, et al.. (2025). Mepolizumab reduced healthcare resource utilization and improved work productivity in patients with severe asthma during the REALITI-A 2-year study. Journal of Asthma. 62(12). 2114–2124.

Han, Joseph K., Joaquim Mullol, Martin Wagenmann, et al.. (2025). Mepolizumab Is Efficacious in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With One or Multiple Prior Nasal Polyps (NP) Surgeries: SYNAPSE Outcomes. Journal of Allergy and Clinical Immunology. 155(2). AB300–AB300.

Li, Yaqin, et al.. (2024). Carboxymethyl chitosan nanoparticle-modulated cationic hydrogels doped with copper ions for combating bacteria and facilitating wound healing. Frontiers in Bioengineering and Biotechnology. 12. 1429771–1429771. 5 indexed citations

Mullol, Joaquim, Vibeke Backer, Jannis Constantinidis, et al.. (2024). Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma. Rhinology Journal. 0(0). 0–0. 2 indexed citations

Mullol, J, et al.. (2024). The impact of mepolizumab on sleep impairment in CRSwNP: post hoc analyses of SYNAPSE and MUSCA. Rhinology Journal. 0(0). 0–0. 1 indexed citations

Yu, Miao, et al.. (2024). Evaluation of living bacterial therapy assisted by pH/reactive oxygen species dual-responsive sodium alginate-based hydrogel for wound infections. International Journal of Biological Macromolecules. 271(Pt 2). 132536–132536. 8 indexed citations

Li, Angela, Liaofu Luo, Wei Du, et al.. (2023). P2.05-10 The Power for PD-L1 Expression to Predict Immune Checkpoint Blockade Outcomes is Determined by Tumor Transcriptome. Journal of Thoracic Oncology. 18(11). S311–S312.

Wang, Junjie, Lili Kong, Xing Wang, et al.. (2022). ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis. International Journal of Biological Macromolecules. 222(Pt A). 1476–1486. 89 indexed citations

Ding, Jianxun, et al.. (2020). lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424. SHILAP Revista de lepidopterología. 1 indexed citations

10.

Cheng, Yu, et al.. (2020). Circular RNA CircPRMT5 Accelerates Proliferation and Invasion of Papillary Thyroid Cancer Through Regulation of miR-30c/E2F3 Axis. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Fam, Maged D, Hussein A. Zeineddine, Steven Mayo, et al.. (2017). Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases. Cerebrovascular Diseases. 43(5-6). 223–230. 7 indexed citations

12.

Lee, Gina, Brenda Auffinger, Donna Guo, et al.. (2016). Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model. Molecular Cancer Therapeutics. 15(12). 3064–3076. 94 indexed citations

13.

Chang, Alan L., Jason Miska, Derek A. Wainwright, et al.. (2016). CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Research. 76(19). 5671–5682. 479 indexed citations breakdown →

14.

Kanojia, Deepak, Ramin A. Morshed, Lingjiao Zhang, et al.. (2015). βIII-Tubulin Regulates Breast Cancer Metastases to the Brain. Molecular Cancer Therapeutics. 14(5). 1152–1161. 42 indexed citations

15.

Kanojia, Deepak, Irina V. Balyasnikova, Ramin A. Morshed, et al.. (2015). Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases. Stem Cells. 33(10). 2985–2994. 32 indexed citations

16.

Yu, Dou, Ramin A. Morshed, Deepak Kanojia, et al.. (2015). Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma. Journal of Nuclear Medicine. 57(2). 279–284. 74 indexed citations

17.

Wainwright, Derek A., Alan L. Chang, Mahua Dey, et al.. (2014). Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors. Clinical Cancer Research. 20(20). 5290–5301. 448 indexed citations

18.

Thaçi, Bart, Atique U. Ahmed, Ilya V. Ulasov, et al.. (2014). Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma. Cancer Gene Therapy. 21(1). 38–44. 34 indexed citations

19.

King, Andrea C., Dingcai Cao, Lingjiao Zhang, & Sandra Yu Rueger. (2013). Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial. Addiction. 108(10). 1836–1844. 16 indexed citations

20.

Tobias, Alex L., Bart Thaçi, Brenda Auffinger, et al.. (2013). The Timing of Neural Stem Cell-Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma. Stem Cells Translational Medicine. 2(9). 655–666. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact